Medicare Enrolled
Dr. Igor Smelyansky, M.D.
Pain Medicine · Roswell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smelyansky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smelyansky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smelyansky
Dr. Igor Smelyansky is a pain medicine specialist in Roswell, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Smelyansky performed 4,091 Medicare services across 1,357 unique beneficiaries.
Between the years covered by Open Payments, Dr. Smelyansky received a total of $12,962 from 54 pharmaceutical and/or device companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smelyansky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in GA
$12,962 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,091
Medicare services
Top 21% in GA for pain medicine
1,357
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~215 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,962 | $85 | $259 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
542 | $50 | $179 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
485 | $58 | $135 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
303 | $1 | $10 |
| Behavioral health care management, 20+ minutes This service involves clinical staff time directed by a healthcare professional to manage behavioral health conditions. It requires at least 20 minutes of dedicated clinical staff time. |
228 | $27 | $89 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $116 | $347 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
57 | $54 | $142 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
54 | $196 | $608 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
45 | $43 | $165 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
44 | $9 | $30 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
41 | $374 | $980 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
41 | $204 | $498 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
40 | $11 | $135 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
36 | $0 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $109 | $391 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
28 | $178 | $445 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
28 | $97 | $230 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
22 | $81 | $214 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
20 | $155 | $418 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $71 | $256 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,962
Total received (2018-2024)
Avg $1,852/year across 7 years
Top 21% in GA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
697
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,962 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,920
2023
$1,853
2022
$2,953
2021
$2,901
2020
$483
2019
$1,033
2018
$1,820
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Curonix LLC
$508
Collegium Pharmaceutical, Inc.
$383
Medtronic, Inc.
$260
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$246
PFIZER INC.
$214
ABBVIE INC.
$162
Choice Spine, LLC
$60
Lundbeck LLC
$20
Azurity Pharmaceuticals, Inc.
$20
VERTEX PHARMACEUTICALS INCORPORATED
$17
Averitas Pharma Inc.
$16
Abbott Laboratories
$13
Top 3 companies account for 60.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,764
Collegium Pharmaceutical, Inc.
$1,303
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,052
PFIZER INC.
$816
Daiichi Sankyo Inc.
$595
ABBVIE INC.
$586
AbbVie Inc.
$528
Curonix LLC
$522
Biohaven Pharmaceutical Holding Company Ltd.
$399
Amgen Inc.
$377
Nevro Corp.
$373
IMPEL PHARMACEUTICALS INC.
$342
Scilex Pharmaceuticals Inc.
$287
Lilly USA, LLC
$281
Abbott Laboratories
$273
Boston Scientific Corporation
$250
SCILEX PHARMACEUTICALS INC.
$210
ARBOR PHARMACEUTICALS, INC.
$185
Hikma Pharmaceuticals USA
$142
BioDelivery Sciences International, Inc.
$130
Centinel Spine, LLC
$124
Pernix Therapeutics Holdings, Inc.
$122
Medtronic USA, Inc.
$100
IBSA Pharma Inc.
$94
Shionogi Inc
$93
Purdue Pharma L.P.
$71
Biohaven Pharmaceuticals, Inc.
$71
SPR Therapeutics, Inc
$70
Lundbeck LLC
$65
Choice Spine, LLC
$60
RedHill Biopharma Inc.
$60
Azurity Pharmaceuticals, Inc.
$48
Novartis Pharmaceuticals Corporation
$48
ASSERTIO THERAPEUTICS, Inc.
$41
Bioventus LLC
$39
Orthogenrx Inc.
$38
Kaleo, Inc.
$37
GRT US Holding, Inc.
$37
Allergan, Inc.
$32
Arbor Pharmaceuticals, Inc.
$31
Sentynl Therapeutics, Inc.
$30
BOSTON SCIENTIFIC CORPORATION
$25
Fidia Pharma USA Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
PAINTEQ LLC
$22
FIDIA PHARMA USA INC.
$22
VERTEX PHARMACEUTICALS INCORPORATED
$17
Averitas Pharma Inc.
$16
Amneal Pharmaceuticals LLC
$16
ASSERTIO THERAPEUTICS, INC.
$16
Almatica Pharma LLC
$15
Flexion Therapeutics, Inc.
$14
DePuy Synthes Sales Inc.
$13
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · Aimovig · BELBUCA · BLACKHAWK CERVICAL SPACER SYSTEM · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CD HORIZON · COMIRNATY · Durolane · EMGALITY · ETERNA · EVZIO · GENERAL PAIN MANAGEMENT · GRALISE · GenVisc 850 · Gralise · HORIZANT · HYALGAN · HYMOVIS · HYSINGLA ER · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · Kloxxado · LICART · LUCEMYRA · LYRICA · LYVISPAH · Levorphanol Tartrate · Licart · MONOVISC · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NURTEC ODT · Octrode SCS Leads · Omnia · PAINTEQ · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PRODISC C · Proclaim Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · SPECTRA WAVEWRITER · SPRINT PNS System · SYMPROIC · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · Symproic · TriVisc sodium hyaluronate · Trudhesa · UBRELVY · VYEPTI · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
17
Per 100K population
1.6
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smelyansky is a clinical cardiology specialist, with above-average Medicare volume (top 21% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smelyansky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Smelyansky performed 1,962 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smelyansky receive payments from pharmaceutical companies?
Yes. Dr. Smelyansky received a total of $12,962 from 54 companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smelyansky's costs compare to other pain medicines in Roswell?
Dr. Smelyansky's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smelyansky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Roswell
Browse pain medicines in Roswell ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in GA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in GA
Which GA pain medicines receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology